Eton Pharmaceuticals, Inc. (ETON)
55.36
+3.38
(+6.50%)
USD |
NASDAQ |
Oct 02, 16:00
55.37
+0.01
(+0.02%)
After-Hours: 20:00
Eton Pharmaceuticals Price : 55.36 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 52.42 | 56.00 | 52.00 | 55.36 | 750078.0 |
| Oct 01, 2026 | 50.18 | 54.00 | 49.67 | 51.98 | 1.327M |
| Sep 30, 2026 | 59.61 | 59.66 | 48.79 | 51.49 | 1.811M |
| Sep 29, 2026 | 58.88 | 59.73 | 57.90 | 59.19 | 710719.0 |
| Sep 28, 2026 | 57.68 | 59.72 | 56.01 | 59.18 | 390726.0 |
| Sep 25, 2026 | 60.00 | 60.60 | 57.22 | 57.68 | 514397.0 |
| Sep 24, 2026 | 56.19 | 59.62 | 55.34 | 59.49 | 725851.0 |
| Sep 23, 2026 | 56.96 | 56.97 | 54.24 | 55.61 | 436089.0 |
| Sep 22, 2026 | 55.31 | 57.50 | 55.01 | 57.09 | 484060.0 |
| Sep 21, 2026 | 55.50 | 56.74 | 53.60 | 55.31 | 335508.0 |
| Sep 18, 2026 | 56.97 | 57.50 | 55.41 | 55.50 | 891703.0 |
| Sep 17, 2026 | 57.04 | 58.00 | 55.90 | 57.07 | 314164.0 |
| Sep 16, 2026 | 54.76 | 56.84 | 54.75 | 56.35 | 336214.0 |
| Sep 15, 2026 | 57.30 | 57.44 | 54.13 | 54.93 | 543868.0 |
| Sep 14, 2026 | 58.29 | 58.97 | 57.32 | 57.62 | 352197.0 |
| Sep 11, 2026 | 58.99 | 59.98 | 56.44 | 57.08 | 323593.0 |
| Sep 10, 2026 | 58.78 | 59.55 | 57.61 | 57.88 | 281699.0 |
| Sep 09, 2026 | 58.91 | 60.43 | 58.66 | 58.83 | 373711.0 |
| Sep 08, 2026 | 57.37 | 59.98 | 56.11 | 59.34 | 396341.0 |
| Sep 04, 2026 | 59.87 | 59.94 | 56.93 | 58.45 | 521604.0 |
| Sep 03, 2026 | 61.96 | 62.39 | 59.70 | 59.90 | 497556.0 |
| Sep 02, 2026 | 61.15 | 62.91 | 59.59 | 61.96 | 577766.0 |
| Sep 01, 2026 | 60.41 | 61.72 | 59.89 | 60.43 | 564615.0 |
| Aug 31, 2026 | 59.04 | 60.61 | 58.24 | 60.44 | 768010.0 |
| Aug 28, 2026 | 61.98 | 62.12 | 58.33 | 59.78 | 588746.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pfizer Inc. | 27.80 |
| Elite Pharmaceuticals, Inc. | 0.2286 |
| Daré Bioscience, Inc. | 0.8428 |
| Liquidia Corp. | 28.64 |
| ANI Pharmaceuticals, Inc. | 72.18 |
Price Related Metrics
| PE Ratio | 146.34 |
| PS Ratio | 16.05 |
| Price to Book Value | 33.62 |
| Earnings Yield | 0.68% |
| Market Cap | 1.566B |
| Operating PE Ratio | 102.69 |
| Normalized PE Ratio | 144.43 |